VRML Share Price

Open 1.89 Change Price %
High 2.66 1 Day 0.32 18.29
Low 1.89 1 Week 0.30 16.95
Close 2.07 1 Month 0.76 58.02
Volume 2279912 1 Year 0.65 45.77
52 Week High 2.66
52 Week Low 0.76
VRML Important Levels
Resistance 2 2.78
Resistance 1 2.49
Pivot 2.21
Support 1 1.65
Support 2 1.36
NASDAQ USA Most Active Stocks
SCHN 26.75 0.38%
SCHN 26.75 0.38%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
DCTH 0.17 6.25%
More..
NASDAQ USA Top Gainers Stocks
LLEN 0.02 100.00%
SPIR 0.02 100.00%
LOCM 0.09 50.00%
GALT 1.94 31.97%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
AEHR 4.99 21.41%
BGMD 0.12 20.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LIWA 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Vermillion, Inc. (NASDAQ: VRML)

VRML Technical Analysis 5
As on 21st Feb 2017 VRML Share Price closed @ 2.07 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.25 & Strong Buy for SHORT-TERM with Stoploss of 1.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
VRML Target for February
1st Target up-side 1.49
2nd Target up-side 1.66
3rd Target up-side 1.83
1st Target down-side 0.99
2nd Target down-side 0.82
3rd Target down-side 0.65
VRML Other Details
Segment EQ
Market Capital 18049096.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.vermillion.com
VRML Address
VRML
Building III
Suite 100
Austin, TX 78738
United States
Phone: 512-519-0400
Fax: 512-439-6980
VRML Latest News
Shares Making an Appearance on Today's Most Volatile List: Vermillion, Inc ...   Aiken Advocate   - 21st Feb 17
Bustling Stock in Focus: Vermillion, Inc. (NASDAQ:VRML)   Aiken Advocate   - 21st Feb 17
Vermillion, Inc. (VRML) Insider Larry N. Feinberg Purchases 617731 Shares of Stock   Sports Perspectives   - 21st Feb 17
Vermillion, Inc. (NASDAQ:VRML) Pops Higher on New Investment   The Oracle Dispatch   - 18th Feb 17
Vermillion Announces Equity Financing of $5.6 Million   PR Newswire (press release)   - 14th Feb 17
Vermillion Announces Appointment of Chief Medical Officer   PR Newswire (press release)   - 15th Nov 16
ASPiRA LABS' OVA1 Technology Receives "Level B" Recommendation in the Latest ...   PR Newswire (press release)   - 10th Nov 16
Broker Changes For Vermillion, Inc. (VRML)   NewsDen   - 06th Jun 16
Vermillion to Showcase Comparison of Overa™ and ROMA™ Algorithms at ACOG ...   PR Newswire (press release)   - 16th May 16
Vermillion Announces FDA Clearance of Overa®, Second Generation OVA1® Test   PR Newswire (press release)   - 21st Mar 16
Interactive Technical Analysis Chart Vermillion, Inc. ( VRML NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Vermillion, Inc.
VRML Business Profile
Vermillion, Inc. is engaged in the discovery, development and commercialization of diagnostic tests that helps physicians diagnose, treat and improve outcomes for patients. The Company's tests are intended to help guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. The Company combines multiple biomarkers into a single, reportable index score. The Company concentrates its development of diagnostic tests in the fields of oncology, cardiology and women�s health, with the initial focuses on ovarian cancer.The Company's product, OVA1, addresses a clear unmet clinical need, namely the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor.In addition to OVA1, the Company has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease.